Shao-Xia Wang Selected Research

salvianolate

1/2022	Xueshuantong injection combined with Salvianolate lyophilized injection improves the synaptic plasticity against focal cerebral ischemia/reperfusion injury in rats through PI3K/AKT/mTOR and RhoA/ROCK pathways.
1/2021	Effects of salvianolate lyophilized injection combined with Xueshuantong injection in regulation of BBB function in a co-culture model of endothelial cells and pericytes.
6/2018	Xueshuantong injection (lyophilized) combined with salvianolate lyophilized injection protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shao-Xia Wang Research Topics

Disease

3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 12/2011
3	Brain Ischemia (Cerebral Ischemia) 01/2022 - 10/2013
3	Reperfusion Injury 01/2022 - 06/2018
3	Inflammation (Inflammations) 11/2020 - 10/2013
2	Stroke (Strokes) 01/2021 - 05/2019
2	Neoplasms (Cancer) 01/2020 - 10/2016
1	Ischemic Stroke 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Body Weight (Weight, Body) 11/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2019
1	Cerebral Infarction 06/2018
1	Liposarcoma 10/2016
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2015
1	Hepatitis 01/2015
1	Coronary Disease (Coronary Heart Disease) 10/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 06/2013
1	Heart Failure 06/2013
1	Brain Infarction 12/2011
1	Neuroinflammatory Diseases 07/2010

Drug/Important Bio-Agent (IBA)

4	Neuroprotective AgentsIBA 01/2022 - 07/2010
4	Panax notoginseng extractIBA 01/2022 - 06/2018
3	salvianolateIBA 01/2022 - 06/2018
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2020
2	Caspase 3 (Caspase-3)IBA 11/2020 - 05/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020 - 05/2019
2	CytokinesIBA 01/2015 - 10/2013
1	notoginsenoside R1IBA 01/2021
1	salvianolic acid BIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 11/2020
1	Cell Adhesion Molecule-1IBA 11/2020
1	Streptozocin (Streptozotocin)FDA Link 11/2020
1	Tight Junction ProteinsIBA 11/2020
1	dabrafenibIBA 01/2020
1	OccludinIBA 05/2019
1	shuxuetongIBA 05/2019
1	Protein Kinases (Protein Kinase)IBA 05/2019
1	Messenger RNA (mRNA)IBA 05/2019
1	Superoxides (Superoxide)IBA 05/2019
1	Interleukin-6 (Interleukin 6)IBA 05/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2019
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2019
1	I-kappa B Proteins (I kappa B)IBA 05/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2019
1	I-kappa B KinaseIBA 05/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2019
1	Claudin-5IBA 05/2019
1	GTP-Binding Proteins (G-Protein)IBA 10/2016
1	Concanavalin AIBA 01/2015
1	danhongIBA 10/2013
1	ChemokinesIBA 10/2013
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2013
1	ProteomeIBA 10/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2013
1	Glucose (Dextrose)FDA LinkGeneric 12/2011
1	Oxygen (Dioxygen)IBA 12/2011
1	scutellarinIBA 12/2011

Therapy/Procedure

1	Injections 01/2021
1	Electrodes (Electrode) 01/2020
1	Intraperitoneal Injections 12/2011